Celldex Therapeutics Inc.

Celldex Therapeutics, Inc. is a New Jersey–based biopharma developing innovative monoclonal and bispecific antibodies for severe inflammatory and allergic diseases, including chronic urticaria and eosinophilic esophagitis.

Headquarters: United States (USA)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 186
HQ: Hampton

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CLDX	Celldex Therapeutics Inc. Cap: 1.8B	EQUITY	NMS	USD	US15117B2025	Active	📈